IL-23, rather than IL-17, is crucial for the development of ovalbumin-induced allergic rhinitis

Molecular Immunology

Volumn 67, Issue 2, 2015, Pages 436-443

  Guo, Chaobin ^a   Chen, Guie ^b   Ge, Ruifeng ^c  

^a QINGDAO MUNICIPAL HOSPITAL   (China)

^b The Third People's Hospital of Qingdao ^*  (China)

^c QINGDAO UNIVERSITY   (China)

Author keywords

Allergic rhinitis; Eosinophil; IL 17; IL 23

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 4; OVALBUMIN;

ALLERGIC RHINITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHIL; FEMALE; GOBLET CELL; IMMUNOCOMPETENT CELL; LYMPH NODE CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH2 CELL; ANIMAL; BIOSYNTHESIS; BONE MARROW CELL; C57BL MOUSE; CHEMICALLY INDUCED; CYTOLOGY; DISEASE MODEL; EOSINOPHILIA; HUMAN; HYPERPLASIA; IMMUNOLOGY; LEUKOCYTE; METABOLISM; PATHOLOGY; STEM CELL; UPREGULATION;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; EOSINOPHILIA; FEMALE; GOBLET CELLS; HUMANS; HYPERPLASIA; INTERLEUKIN-17; INTERLEUKIN-23; INTERLEUKIN-4; LEUKOCYTES; MICE, INBRED C57BL; OVALBUMIN; RHINITIS, ALLERGIC; STEM CELLS; TH2 CELLS; UP-REGULATION;

EID: 84940889265     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2015.07.009     Document Type: Article

References (34)

1. Annunziato F., Cosmi L., Santarlasci V., Maggi L., Liotta F., Mazzinghi B., Parente E., Fili L., Ferri S., Frosali F., Giudici F., Romagnani P., Parronchi P., Tonelli F., Maggi E., Romagnani S. Phenotypic and functional features of human Th17 cells. J. Exp. Med. 2007, 204:1849-1861.
2. Bousquet J., Burney P.G., Zuberbier T., Cauwenberge P.V., Akdis C.A., Bindslev-Jensen C., Bonini S., Fokkens W.J., Kauffmann F., Kowalski M.L., Lodrup-Carlsen K., Mullol J., Nizankowska-Mogilnicka E., Papadopoulos N., Toskala E., Wickman M., Anto J., Auvergne N., Bachert C., Bousquet P.J., Brunekreef B., Canonica G.W., Carlsen K.H., Gjomarkaj M., Haahtela T., Howarth P., Lenzen G., Lotvall J., Radon K., Ring J., Salapatas M., Schunemann H.J., Szczecklik A., Todo-Bom A., Valovirta E., von Mutius E., Zock J.P. GA2LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma 'epidemic'. Allergy 2009, 64:969-977.
3. Ciprandi G., De Amici M., Murdaca G., Fenoglio D., Ricciardolo F., Marseglia G., Tosca M. Serum interleukin-17 levels are related to clinical severity in allergic rhinitis. Allergy 2009, 64:1375-1378.
4. Ciprandi G., Fenoglio D., De Amici M., Quaglini S., Negrini S., Filaci G. Serum IL-17 levels in patients with allergic rhinitis. J. Allergy Clin. Immunol. 2008, 122:650 e2-651 e2.
5. Cornelissen F., van Hamburg J.P., Lubberts E. The IL-12/IL-23 axis and its role in Th17 cell development, pathology and plasticity in arthritis. Curr. Opin. Investig. Drugs 2009, 10:452-462.
6. Di Cesare A., Di Meglio P., Nestle F.O. The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J. Invest Dermatol. 2009, 129:1339-1350.
7. Gaddam S.L., Priya V.H., Babu B.M., Joshi L., Venkatasubramanian S., Valluri V. Association of interleukin-10 gene promoter polymorphism in allergic patients. Genet. Test. Mol. Biomarkers 2012, 16:632-635.
8. Genuneit J., Cantelmo J.L., Weinmayr G., Wong G.W., Cooper P.J., Riikjarv M.A., Gotua M., Kabesch M., von Mutius E., Forastiere F., Crane J., Nystad W., El-Sharif N., Batlles-Garrido J., Garcia-Marcos L., Garcia-Hernandez G., Morales-Suarez-Varela M., Nilsson L., Braback L., Saraclar Y., Weiland S.K., Cookson W.O., Strachan D., Moffatt M.F., Group I.P.S. A multi-centre study of candidate genes for wheeze and allergy: the International Study of Asthma and Allergies in Childhood Phase 2. Clin. Exp. Allergy 2009, 39:1875-1888.
9. Gregory L.G., Jones C.P., Walker S.A., Sawant D., Gowers K.H., Campbell G.A., McKenzie A.N., Lloyd C.M. IL-25 drives remodelling in allergic airways disease induced by house dust mite. Thorax 2013, 68:82-90.
10. Grivennikov S.I., Wang K., Mucida D., Stewart C.A., Schnabl B., Jauch D., Taniguchi K., Yu G.Y., Osterreicher C.H., Hung K.E., Datz C., Feng Y., Fearon E.R., Oukka M., Tessarollo L., Coppola V., Yarovinsky F., Cheroutre H., Eckmann L., Trinchieri G., Karin M. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 2012, 491:254-258.
11. Haenuki Y., Matsushita K., Futatsugi-Yumikura S., Ishii K.J., Kawagoe T., Imoto Y., Fujieda S., Yasuda M., Hisa Y., Akira S., Nakanishi K., Yoshimoto T. A critical role of IL-33 in experimental allergic rhinitis. J. Allergy Clin. Immunol. 2012, 130:184e11-194e11.
12. Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., Weaver C.T. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005, 6:1123-1132.
13. Haworth O., Cernadas M., Yang R., Serhan C.N., Levy B.D. Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation. Nat. Immunol. 2008, 9:873-879.
14. Helbling M., Lukesch A., Haimovici A., Karamitopoulou E., Berger M.D., Hadrich M., Mallaev M., Schnuriger B., Koelzer V.H., Dawson H., Borner M., Langer R., Rosenberg R., Nitsche U., Inderbitzin D., Lugli A., Tschan M., Zlobec I. Investigation of IL-23 (p19, p40) and IL-23R identifies nuclear expression of IL-23 p19 as a favorable prognostic factor in colorectal cancer: a retrospective multicenter study of 675 patients. Oncotarget 2014, 5:4671-4682.
15. Holgate S.T. The epidemic of allergy and asthma. Nature 1999, 402:B2-B4.
16. Ibrahim G.H., ElTabbakh M.T., Gomaa A.H., Mohamed E.A. Interleukin-18 gene polymorphisms in Egyptian patients with allergic diseases. Am. J. Rhinol. Allergy 2012, 26:385-389.
17. Kastelein R.A., Hunter C.A., Cua D.J. Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Ann. Rev. Immunol. 2007, 25:221-242.
18. Korn T., Bettelli E., Oukka M., Kuchroo V.K. IL-17 and Th17 cells. Ann. Rev. Immunol. 2009, 27:485-517.
19. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., McClanahan T., Kastelein R.A., Cua D.J. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 2005, 201:233-240.
20. Li Y., Sun M., Cheng H., Li S., Liu L., Qiao H., Hua S., Lu J. Silencing IL-23 expression by a small hairpin RNA protects against asthma in mice. Exp. Mol. Med. 2011, 43:197-204.
21. Mathias C.B., Freyschmidt E.J., Caplan B., Jones T., Poddighe D., Xing W., Harrison K.L., Gurish M.F., Oettgen H.C. IgE influences the number and function of mature mast cells, but not progenitor recruitment in allergic pulmonary inflammation. J. Immunol. 2009, 182:2416-2424.
22. McGeachy M.J., Bak-Jensen K.S., Chen Y., Tato C.M., Blumenschein W., McClanahan T., Cua D.J. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat. Immunol. 2007, 8:1390-1397.
23. Nieminen K., Valovirta E., Savolainen J. Clinical outcome and IL-17, IL-23, IL-27 and FOXP3 expression in peripheral blood mononuclear cells of pollen-allergic children during sublingual immunotherapy. Pediatr. Allergy Immunol. 2010, 21:e174-e184.
24. Saito H., Matsumoto K., Denburg A.E., Crawford L., Ellis R., Inman M.D., Sehmi R., Takatsu K., Matthaei K.I., Denburg J.A. Pathogenesis of murine experimental allergic rhinitis: a study of local and systemic consequences of IL-5 deficiency. J. Immunol. 2002, 168:3017-3023.
25. Sarra M., Pallone F., Macdonald T.T., Monteleone G. IL-23/IL-17 axis in IBD. Inflamm. Bowel Dis. 2010, 16:1808-1813.
26. Schnyder-Candrian S., Togbe D., Couillin I., Mercier I., Brombacher F., Quesniaux V., Fossiez F., Ryffel B., Schnyder B. Interleukin-17 is a negative regulator of established allergic asthma. J. Exp. Med. 2006, 203:2715-2725.
27. Shaaban R., Zureik M., Soussan D., Neukirch C., Heinrich J., Sunyer J., Wjst M., Cerveri I., Pin I., Bousquet J., Jarvis D., Burney P.G., Neukirch F., Leynaert B. Rhinitis and onset of asthma: a longitudinal population-based study. Lancet 2008, 372:1049-1057.
28. Sherlock J.P., Taylor P.C., Buckley C.D. The biology of IL-23 and IL-17 and their therapeutic targeting in rheumatic diseases. Curr. Opin. Rheumatol. 2015, 27:71-75.
29. Tomazic P.V., Birner-Gruenberger R., Leitner A., Obrist B., Spoerk S., Lang-Loidolt D. Nasal mucus proteomic changes reflect altered immune responses and epithelial permeability in patients with allergic rhinitis. J. Allergy Clin. Immunol. 2014, 133:741-750.
30. Wakashin H., Hirose K., Maezawa Y., Kagami S., Suto A., Watanabe N., Saito Y., Hatano M., Tokuhisa T., Iwakura Y., Puccetti P., Iwamoto I., Nakajima H. IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice. Am. J. Respir. Crit. Care Med. 2008, 178:1023-1032.
31. Wang M., Zhang W., Shang J., Yang J., Zhang L., Bachert C. Immunomodulatory effects of IL-23 and IL-17 in a mouse model of allergic rhinitis. Clin. Exp. Allergy 2013, 43:956-966.
32. Wilson N.J., Boniface K., Chan J.R., McKenzie B.S., Blumenschein W.M., Mattson J.D., Basham B., Smith K., Chen T., Morel F., Lecron J.C., Kastelein R.A., Cua D.J., McClanahan T.K., Bowman E.P., de Waal Malefyt R. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 2007, 8:950-957.
33. Xu C., Hao K., Yu L., Zhang X. Serum interleukin-17 as a diagnostic and prognostic marker for non-small cell lung cancer. Biomarkers 2014, 19:287-290. (biochemical indicators of exposure, response, and susceptibility to chemicals).
34. Zarogoulidis P., Katsikogianni F., Tsiouda T., Sakkas A., Katsikogiannis N., Zarogoulidis K. Interleukin-8 and interleukin-17 for cancer. Cancer Investig. 2014, 32:197-205.